Alpha 2.0
Login Register
» Articles » PMID: 33958010

Associations of Facility-level Antibiotic Use and Hospital-onset Infection in US Acute-care Hospitals, 2012-2018

Overview
Journal Infect Control Hosp Epidemiol
Publisher Cambridge University Press
Specialties Health Services
Infectious Diseases
Nursing
Public Health
Date 2021 May 7
PMID 33958010
Citations 6
Authors
Sophia V Kazakova
James Baggs
Sarah H Yi
Sujan C Reddy
Kelly M Hatfield
Alice Y Guh
John A Jernigan
L Clifford McDonald
Affiliations
Soon will be listed here.
Abstract

Previously reported associations between hospital-level antibiotic use and hospital-onset infection (HO-CDI) were reexamined using 2012-2018 data from a new cohort of US acute-care hospitals. This analysis revealed significant positive associations between total, third-generation, and fourth-generation cephalosporin, fluoroquinolone, carbapenem, and piperacillin-tazobactam use and HO-CDI rates, confirming previous findings.

Citing Articles

Environmental approaches to controlling Clostridioides difficile infection in healthcare settings.

Carling P, Parry M, Olmstead R Antimicrob Resist Infect Control. 2023; 12(1):94.

PMID: 37679758 PMC: 10483842. DOI: 10.1186/s13756-023-01295-z.

Impact of the COVID-19 pandemic on the incidence of healthcare-associated infection in a tertiary healthcare facility in the Republic of Ireland.

Ali S, McDermott S Infect Prev Pract. 2023; 5(3):100300.

PMID: 37554737 PMC: 10404766. DOI: 10.1016/j.infpip.2023.100300.

Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020.

Okafor C, Clogher P, Olson D, Niccolai L, Hadler J Emerg Infect Dis. 2023; 29(5).

PMID: 37081745 PMC: 10124664. DOI: 10.3201/eid2905.221294.

Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of infection treated with vancomycin.

Merchante N, Herrero R, Valverde-Fredet M, Rodriguez-Fernandez M, Pinagorte H, Martinez-Marcos F JAC Antimicrob Resist. 2023; 5(2):dlad033.

PMID: 36968953 PMC: 10035639. DOI: 10.1093/jacamr/dlad033.

Trends in facility-level rates of infections in US hospitals, 2019-2020.

Rose A, Baggs J, Kazakova S, Guh A, Yi S, McCarthy N Infect Control Hosp Epidemiol. 2022; 44(2):238-245.

PMID: 35586888 PMC: 10976319. DOI: 10.1017/ice.2022.69.

References
1.
Baggs J, Fridkin S, Pollack L, Srinivasan A, Jernigan J . Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012. JAMA Intern Med. 2016; 176(11):1639-1648. PMC: 10863902. DOI: 10.1001/jamainternmed.2016.5651. View
2.
Turner N, Grambow S, Woods C, Fowler Jr V, Moehring R, Anderson D . Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network. JAMA Netw Open. 2019; 2(10):e1914149. PMC: 6824221. DOI: 10.1001/jamanetworkopen.2019.14149. View
3.
Kazakova S, Baggs J, McDonald L, Yi S, Hatfield K, Guh A . Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis. Clin Infect Dis. 2019; 70(1):11-18. DOI: 10.1093/cid/ciz169. View
4.
Gagne J, Glynn R, Avorn J, Levin R, Schneeweiss S . A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011; 64(7):749-59. PMC: 3100405. DOI: 10.1016/j.jclinepi.2010.10.004. View
5.
Fridkin S, Baggs J, Fagan R, Magill S, Pollack L, Malpiedi P . Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014; 63(9):194-200. PMC: 4584728. View